Reply to Mengxin Lu, Yi Zhang, Yu Xiao's Letter to the Editor, re: Kimmo Kettunen, Peter J. Bostrom, Tarja Lamminen, et al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells. Eur Urol 2019;76:430-4




Kimmo Kettunen, Peter J. Boström, Pekka Taimen

PublisherELSEVIER

2019

European Urology

EUROPEAN UROLOGY

EUR UROL

76

5

E137

E138

2

0302-2838

1873-7560

DOIhttps://doi.org/10.1016/j.eururo.2019.07.049




Last updated on 2024-26-11 at 21:22